DEMO

Log In | Sign Up



Thermo Fisher Scientific

Selected Articles

2025-08-14
ETF Daily News
Rep. Rick W. Allen Purchases Shares of The Charles Schwab Corporation (NYSE:SCHW)
2025-08-14
ETF Daily News
Promising Biotech Stocks Worth Watching – August 12th
2025-08-14
The Times of India
China pharma firms turn to local reagent suppliers to cut costs and delivery times
2025-08-13
Yahoo Entertainment
China pharma firms turn to local reagent suppliers to cut costs and delivery times
2025-08-13
GlobeNewswire
Demand for Global Mass Spectrometry Market Size to Surpass USD 14.49 Billion by 2034, Exhibit a CAGR of 7.70% - Comprehensive Research Report by Zion Market Research
2025-08-13
GlobeNewswire
Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi
2025-08-13
GlobeNewswire
U.S. Pharmaceutical CDMO Market Valuation to Surpass USD 68.57 Billion by 2034
2025-08-13
Plos.org
ERK-METTL3 axis acts as a novel regulator of antiviral innate immunity combating pseudorabies virus infection
2025-08-13
Plos.org
A common polymorphism in the human immunoreceptor NKp65 determines ligand interaction, cell surface expression and function
2025-08-13
Plos.org
Anti-obesity compounds, Semaglutide and LiPR, and PrRP do not change the proportion of human and mouse POMC+ neurons

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. US8835561023 www.thermofisher.com